8-K
Current Report
ArriVent BioPharma, Inc. Filed Acc 0001104659-26-094869
Material agreement · Results of operations
- Item 1.01 Entry into a material definitive agreement
- Item 2.02 Results of operations and financial condition
From the SEC's structured data for this filing
Loading tm2622880d1_8k.htm…